Bill Deegan
Gründer bei Cellebration Life Sciences, Inc.
Profil
Bill Deegan is the founder of Cellebration Life Sciences, Inc. He was previously the Chief Financial Officer, Secretary & Treasurer at American Housing Income Trust, Inc.
Aktive Positionen von Bill Deegan
| Unternehmen | Position | Beginn |
|---|---|---|
Cellebration Life Sciences, Inc.
 Cellebration Life Sciences, Inc. BiotechnologyHealth Technology Cellebration Life Sciences, Inc. is a regenerative technology company that is seeking FDA approval to conduct type 2 diabetes clinical trials using stem cell-based treatment. The company is based in Phoenix, AZ and was founded by Siddharth Bhavsar, Tim Kopatich, Deven Patel, Anand Srivastava, and Bill Deegan. The company has partnered with the Institute of Stem Cell Therapy and Research to provide research and treatments for autoimmune diseases and orthopedic injuries. Cellebration's research team is working closely with scientists at Giostar to find cures. Tim Kopatich has been the CEO since incorporation. | Gründer | - |
Ehemalige bekannte Positionen von Bill Deegan
| Unternehmen | Position | Ende |
|---|---|---|
American Housing Income Trust, Inc.
 American Housing Income Trust, Inc. Real Estate Investment TrustsFinance American Housing Income Trust, Inc. engages in the investment, acquisition, management, renovation, rehabilitation, and leasing of single-family residential properties. The company was founded on December 17, 2007 and is headquartered in Phoenix, AZ. | Finanzdirektor/CFO | 24.06.2015 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
American Housing Income Trust, Inc.
American Housing Income Trust, Inc. Real Estate Investment TrustsFinance American Housing Income Trust, Inc. engages in the investment, acquisition, management, renovation, rehabilitation, and leasing of single-family residential properties. The company was founded on December 17, 2007 and is headquartered in Phoenix, AZ. | Finance |
Cellebration Life Sciences, Inc.
Cellebration Life Sciences, Inc. BiotechnologyHealth Technology Cellebration Life Sciences, Inc. is a regenerative technology company that is seeking FDA approval to conduct type 2 diabetes clinical trials using stem cell-based treatment. The company is based in Phoenix, AZ and was founded by Siddharth Bhavsar, Tim Kopatich, Deven Patel, Anand Srivastava, and Bill Deegan. The company has partnered with the Institute of Stem Cell Therapy and Research to provide research and treatments for autoimmune diseases and orthopedic injuries. Cellebration's research team is working closely with scientists at Giostar to find cures. Tim Kopatich has been the CEO since incorporation. | Health Technology |
